google-site-verification: googlec7193c3de77668c9.html
Wednesday , October 14 2026

Scientists develop first-of-its-kind antibody to block Epstein Barr virus

[
Fred Hutch Cancer Center scientists reached a crucial milestone in blocking Epstein Barr virus (EBV), a pathogen estimated to infect 95% of the global population that is linked to multiple types of cancer, neurodegenerative diseases and other chronic health conditions. Using mice with human antibody genes, the research team developed new genetically human monoclonal antibodies that prevent two key antigens on the surface of the virus from binding to and entering human immune cells.


Source link

Advertisements

See also  Boosting contraceptive awareness among diverse young women

Check Also

Inflammation is already elevated at the earliest stage of cardiovascular-kidney-metabolic syndrome

[ A new analysis of U.S. national health data finds that high-sensitivity C-reactive protein (hs-CRP), …

A gut microbe makes a fatty acid that cuts artery plaque in half in mice

[ A common gut bacterium produces a molecule that slows cholesterol production in the liver. …

DR Congo Ebola vaccine trial to begin within weeks: WHO

[ Ebola virus isolated in November 2014 from patient blood samples obtained in Mali. The …

Leave a Reply

Available for Amazon Prime